-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
August 01, 2012 - Diabetic
nephropathy is a rapidly growing problem and its attendant
association with cardiovascular … Such non-diabetic
populations may include older patients and those with
hypertension, cardiovascular … Cardiovascular disease (CVD) is also an important risk
condition that is encompassed by the detection … The risk of cardiovascular
events is higher in Hispanic versus non-Hispanic white adults
with CKD. … The draft CER
focuses on endpoints for end-stage renal disease (ESRD),
cardiovascular disease (CVD)
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-treatment-future_research.pdf
February 01, 2012 - The clinical outcomes of interest are mortality, cardiovascular disease, and diabetes, including
surrogate … The clinical outcomes of interest are mortality,
cardiovascular disease, and diabetes, including surrogate … While a study of mortality would require large sample sizes and long
periods of followup, cardiovascular … It is known that the outcomes of
interest, that is, mortality, cardiovascular disease and diabetes, … Outcomes of interest include adherence, quality of life,
cost, and cardiovascular outcomes.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes.pdf
April 01, 2005 - Robert Safian, MD, FSCAIPeripheral Vascular
Disease Committee
Society for Cardiovascular Angiography … • Limited data on cardiovascular
outcomes. … • Very limited data
on cardiovascular
outcomes. … Other
variables related to
cardiovascular disease
were also found to
predict death. 1 study
found … • N/A
Overall
Summary
• The 2 applicable RCTs
found no difference in
kidney cardiovascular,
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-presentation-format_research.pdf
January 01, 2019 - first expert is primarily a trialist who has designed and
conducted several high impact trials in cardiovascular … : a meta-analysis of randomized trials
2009 JAMA
16418466 Aspirin for the primary prevention of cardiovascular … disease but with cardiovascular risk factors: meta-analysis of
randomised controlled trials
2009 … Intern
Med
17517853 Effect of rosiglitazone on the risk of myocardial infarction and death
from cardiovascular … PMID Title Year Journal
18480116 Effects of different regimens to lower blood pressure on major
cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea_research-protocol.pdf
March 15, 2010 - OSA has been associated with a variety of adverse clinical outcomes, such as mortality
secondary to cardiovascular … gender, body mass index (BMI), existing non-insulin dependent diabetes mellitus
(NIDDM), existing cardiovascular … Cardiovascular events (Congestive heart failure symptoms, stroke, arrhythmia
events, coronary artery … Long-term cardiovascular outcomes in men with
obstructive sleep apnoea-hypopnoea with or without treatment … Sleep-disordered breathing and cardiovascular
disease: cross-sectional results of the Sleep Heart Health
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
January 01, 2010 - Additional support was obtained from the National Cardiovascular Data Registry,
American College of … the elderly: results from 262,700 Medicare patients in
the American College of Cardiology-National Cardiovascular … Methods: Outcomes were evaluated in 262,700 patients from 650 National
Cardiovascular Data Registry … This was accomplished through linkage of the
American College of Cardiology National Cardiovascular … Importantly, the
project was financed by the Agency for Healthcare Research and Quality, Cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
January 01, 2011 - For example, evidence of the benefits of aspirin
for prevention of cardiovascular events from patients … Outcomes Composite outcomes that mix
outcomes of different
significance
Cardiovascular trials frequently … Problems with
use of composite end points in
cardiovascular trials: systematic review of
randomised … Lipid modification:
cardiovascular risk assessment and the
modification of blood lipids for the primary … and secondary prevention of cardiovascular
disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
January 01, 2011 - For example, evidence of the benefits of aspirin
for prevention of cardiovascular events from patients … Outcomes Composite outcomes that mix
outcomes of different
significance
Cardiovascular trials frequently … Problems with
use of composite end points in
cardiovascular trials: systematic review of
randomised … Lipid modification:
cardiovascular risk assessment and the
modification of blood lipids for the primary … and secondary prevention of cardiovascular
disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_disposition-comments.pdf
October 01, 2010 - Journal
Cardiovascular Electrophysiology 2008; 19:762-768.
2. … Journal
Cardiovascular Electrophysiology, 2007; 18:583-588. … Journal
Cardiovascular Electrophysiology 2008; 19:627. … Journal
Cardiovascular Electrophysiology 2008; 19:807. … Journal
Cardiovascular Electrophysiology 2008; 19:621.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/quantitative-synthesis-expanded-methods_methods.pdf
March 01, 2013 - Number needed to treat with statins to prevent one cardiovascular event in 5 years. .... 11
Table 2. … For example, “cardiovascular event (yes/no)” could be
defined as a composite of MI, stroke, and death … from cardiovascular disease. … Number needed to treat with statins to prevent one cardiovascular event in 5 years
Trials
Number … Problems with use of
composite end points in cardiovascular
trials: systematic review of randomised
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
June 01, 2014 - They cited the importance of an
ongoing cardiovascular outcomes trial to determine the true potential … [Qsymia] patients had improved cardiovascular
and metabolic risk factors and a decrease in the need … As one expert representing a research perspective noted,
“Serious potential adverse events (cardiovascular … Obesity and
diabetes are major risk factors for cardiovascular diseases and cancer, hence, an effective … However, the concerns about
20
cardiovascular issues and breast cancer, as well as the likelihood
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-library-afib.pdf
November 15, 2018 - REFERENCE
Survival All-cause
mortality
All-cause mortality Workgroup recommendation
Survival Cardiovascular … death
Cardiovascular death indicates cause of death was sudden cardiac death, MI,
unstable angina … , stroke,
bleeding, atrial fibrillation, repeat AF-ablations, periprocedural complication, other
cardiovascular … Hicks KA, Tcheng JE, Bozkurt B, et al.
2014 ACC/AHA Key Data Elements and
Definitions for Cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0095_04-10-2009.pdf
January 01, 2009 - )
Cardiovascular disease is the leading cause of mortality for women in the US.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
January 15, 2015 - Quality of life
• Change in angina (e.g., worsening)
• MI
• Heart failure
• Stroke
• Death
• Cardiovascular … Forecasting the future of cardiovascular
disease in the United States: a policy statement from the American … Nurses
Association, Society for Cardiovascular Angiography and Interventions, and Society of
Thoracic … of the American College of
Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular … Cardiovascular imaging. 2014 Jun;7(6):593-604. PMID: 24925328.
15.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-seniors-death_research.pdf
August 01, 2007 - nitroglycerin use,
percutaneous coronary interventions, or coronary artery bypass graft surgery), other
cardiovascular … likely than new users of the atypical
agents to have cerebrovascular disease, diabetes, AMI, other cardiovascular … Simultaneous assessment of short-term
gastrointestinal benefits and cardiovascular risks of
selective … infarction 551 2.3% 354 2.7% 1.2 0.05
Other ischemic heart disease 665 2.7% 493 3.8% 1.4 <.0001
Other cardiovascular … disease, congestive heart failure, diabetes, myocardial infarction, other ischemic heart disease, other
cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0255_06-25-2010.pdf
January 01, 2010 - Outcome(s):
• Cardiovascular events (mortality or myocardial infarction)
• In-Stent Restenosis
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-update_executive.pdf
August 01, 2016 - The assessed outcomes
included all-cause and cardiovascular mortality,
cardiovascular events (including … In general, patients with
histories of cardiovascular disease were at increased
risk of adverse clinical … Two studies found no difference
in composite cardiovascular and renal outcomes by age. … Only the CORAL (Cardiovascular Outcomes in
Renal Atherosclerotic Lesions) trial explicitly incorporated … Only one trial of PTRAS
versus medical therapy had a primary clinical outcome
(CORAL: composite cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
September 01, 2015 - Cardiovascular disease
4. Dementia (including Alzheimer’s Disease)
5. … journal from the
American Heart Association that
publishes original medical research
related to cardiovascular … Protection
(ESH)
1, 11
Annual meeting presenting
hypertension and
cardiovascular research
X … Interventions (EuroPCR)
1, 11
Annual meeting presenting
cardiovascular research
X X X X X X X … Therapeutics (TCT)
1, 11
Annual meeting presenting
research on cardiovascular
therapies
X X
-
effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
September 01, 2015 - Cardiovascular disease
4. Dementia (including Alzheimer’s Disease)
5. … journal from the
American Heart Association that
publishes original medical research
related to cardiovascular … Protection
(ESH)
1, 11
Annual meeting presenting
hypertension and
cardiovascular research
X … Interventions (EuroPCR)
1, 11
Annual meeting presenting
cardiovascular research
X X X X X X X … Therapeutics (TCT)
1, 11
Annual meeting presenting
research on cardiovascular
therapies
X X
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
March 13, 2012 - incidence, cervical cancer incidence, venous thromboembolic disease, neurological
conditions, stroke, or cardiovascular … outcomes: diagnosis of breast cancer, cervical cancer, venous
thromboembolic event (VTE), stroke, cardiovascular … lack of
randomized trial data; recent experience with hormone replacement therapy for
prevention of cardiovascular … The balance of other
benefits and harms (particularly cardiovascular and thrombotic risks) may differ … cervical cancer
incidence, venous
thromboembolic
disease, neurological
conditions, stroke, or
cardiovascular